UA108840C2 - Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю - Google Patents

Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю

Info

Publication number
UA108840C2
UA108840C2 UAA201109120A UAA201109120A UA108840C2 UA 108840 C2 UA108840 C2 UA 108840C2 UA A201109120 A UAA201109120 A UA A201109120A UA A201109120 A UAA201109120 A UA A201109120A UA 108840 C2 UA108840 C2 UA 108840C2
Authority
UA
Ukraine
Prior art keywords
composition
docetaxel
basis
increased stability
obtaining medicine
Prior art date
Application number
UAA201109120A
Other languages
English (en)
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UA108840C2 publication Critical patent/UA108840C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Даний винахід пропонує стабільну фармацевтичну композицію, яка містить наночастинки, що містять доцетаксел і біосумісний полімер, де доцетаксел, що використовується для одержання композиції, знаходиться в безводній формі і де композиція не містить поверхнево-активної речовини.
UAA201109120A 2005-08-31 2006-08-30 Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю UA108840C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71286505P 2005-08-31 2005-08-31

Publications (1)

Publication Number Publication Date
UA108840C2 true UA108840C2 (uk) 2015-06-25

Family

ID=41449779

Family Applications (3)

Application Number Title Priority Date Filing Date
UAA200803884A UA95921C2 (uk) 2005-08-31 2006-08-30 Композиції, що включають слабкорозчинні у воді фармацевтичні речовини і протимікробні речовини
UAA201109120A UA108840C2 (uk) 2005-08-31 2006-08-30 Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю
UAA200803886A UA96273C2 (uk) 2005-08-31 2006-08-30 Композиція доцетакселу і цитрату для лікування раку

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200803884A UA95921C2 (uk) 2005-08-31 2006-08-30 Композиції, що включають слабкорозчинні у воді фармацевтичні речовини і протимікробні речовини

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200803886A UA96273C2 (uk) 2005-08-31 2006-08-30 Композиція доцетакселу і цитрату для лікування раку

Country Status (3)

Country Link
NO (1) NO344525B1 (uk)
UA (3) UA95921C2 (uk)
ZA (1) ZA200802763B (uk)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
AU5241199A (en) * 1998-07-30 2000-02-21 Novopharm Biotech Inc. Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
SI21222A (sl) * 2002-05-28 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo nanodelcev
SI1585548T1 (sl) * 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
CA2551117A1 (en) * 2003-12-23 2005-07-14 Abraxis Bioscience, Inc. Substituted melatonin derivatives, process for their preparation, and methods of use

Also Published As

Publication number Publication date
ZA200802763B (en) 2009-10-28
UA95921C2 (uk) 2011-09-26
NO20190306A1 (no) 2008-05-13
NO344525B1 (no) 2020-01-27
UA96273C2 (uk) 2011-10-25

Similar Documents

Publication Publication Date Title
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
GT200600097A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
ATE499090T1 (de) Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
CY1118179T1 (el) Φαρμακευτικη συνθεση
ECSP088239A (es) Composición de liberación de fármaco sostenida
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
ECSP10010310A (es) Nuevos compuestos y composiciones y métodos de uso
MA32394B1 (fr) Composes pegyles d'insuline lispro
RS52633B (en) CANCER TREATMENT FORMULATION
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
DK1543063T3 (da) Medikament levering
DK1796650T3 (da) Transport- og afgivelsesvehikel indeholdende nanopartikler
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
DE602006001699D1 (de) Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
TR200806298A2 (tr) Farmasötik formülasyon
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
CY1116840T1 (el) Χρηση 24-norudca
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
MY142792A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
TW200716581A (en) Benzothiazol-2-one derivatives as inhibitors of lipases and phospholipases